Business Standard

Dr Reddy's Laboratories shuts all units after cyber attack on servers

Security breach comes days after firm got approval to conduct trials for Covid-19 vaccine candidate Sputnik V

Dr Reddy's
Premium

Sohini Das Mumbai
Days after Hyderabad-based drug major Dr Reddy’s Laboratories (DRL) received approval from the Indian drug regulator to conduct phase-2 and 3 trials of the Russian Covid-19 vaccine candidate Sputnik V, the company had to shut its plants across the globe after a cyber attack on its servers. 

This is the second such attack on entities conducting vaccine research or trial. 

In July, Chinese hackers stole information from Spanish laboratories working on a Covid-19 vaccine, according to international news agencies. 

Though DRL’s Chief Information Officer Mukesh Rathi said the firm anticipated to restart services within 24 hours, the stock fell by 3 per cent

What you get on BS Premium?

  • Unlock 30+ premium stories daily hand-picked by our editors, across devices on browser and app.
  • Pick your 5 favourite companies, get a daily email with all news updates on them.
  • Full access to our intuitive epaper - clip, save, share articles from any device; newspaper archives from 2006.
  • Preferential invites to Business Standard events.
  • Curated newsletters on markets, personal finance, policy & politics, start-ups, technology, and more.
VIEW ALL FAQs

Need More Information - write to us at assist@bsmail.in